Elaine Zhang

-Designed and spearheaded the customer success framework and health score metrics system, overseeing a key client portfolio exceeding $420K in ARR. Achieved 100% renewal rate, successfully fending off competitive threats while safeguarding core revenue streams. -Leveraging diagnostic consulting frameworks to unlock expanded product utilization across client organizations, directly generating 3 new revenue streams with measurable improvement in customer retention metrics. -Established and execute a systematic customer feedback loop to precisely identify product and operational pain points, triggering 5 prioritized enhancements to internal product Roadmaps and workflows. This initiative elevated customer satisfaction (NPS surged from 7 to 9) and transformed the end-to-end partnership experience.

-Execute territory plans and sales strategy on expanding Oracle’s Life Science cloud solution’s footprints. -Architecture and execution of Oracle Clinical Solutions GTM strategy across China, pioneering target client mapping by cold calling, LinkedIn outreach and email campaigns. Build strong relationship with key stakeholders across Business Unit, IT, Operation and C-suite level.Secured 6 CRO clients, propelling the business to become the fastest-growing unit in the region. -Manage end to end sales process through the engagement of appropriate resources such as solution consultant or service and partnership and executives to generate sales pipeline and create proposal to work with customers to win new business. -Drove marketing activities and partner engagement initiatives, resulting in expanded market influence and strengthened channel relationships.

Amid transformative shifts driven by China's Volume-Based Procurement (VBP) policy, architected and executed innovative market access and commercial strategies that defended 85% market share for core products in target hospitals, future-proofing revenue streams against systemic disruption. Established and steered a national Glioma Multidisciplinary Team (MDT) Alliance, profoundly reshaping KOL treatment paradigms to propel brand preference rates. This initiative drove 51 consecutive months of sales target overachievement, substantially eclipsing regional and national averages. Architected and cultivated strategic partnerships with oncology KOLs and institutional decision-making echelons, securing Tier hospitals. This cornerstone initiative underpins sustainable market leadership through elite clinical network dominance.

Championed end-to-end order fulfillment excellence and customer success for 50+ Golden Enterprise accounts, consistently achieving 98% on-time delivery and 95% CSAT. Established cross-functional alignment across Demand Planning, Warehousing, Logistics, Sales. Instituted quarterly strategic review forums with C-suite stakeholders, leveraging supply chain health analytics to preempt risks and unlock $2M+ revenue opportunities through data-driven insights.